<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Irritant-induced asthma
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Irritant-induced asthma
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Irritant-induced asthma
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Catherine Lemière, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Hille Suojalehto, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Peter J Barnes, DM, DSc, FRCP, FRS
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Paul Dieffenbach, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Oct 12, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Irritant-induced asthma (IIA) is a type of asthma that results from a single exposure to a high concentration of irritant agents or repeated exposure to moderate to low doses of irritant agents [
         <a href="#rid1">
          1-9
         </a>
         ]. The acute form is also referred to as "reactive airways dysfunction syndrome" (RADS).
        </p>
        <p>
         The diagnosis and management of IIA will be reviewed here. The diagnosis of asthma and the causes, evaluation, and management of occupational asthma are discussed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/543.html" rel="external">
          "Asthma in adolescents and adults: Evaluation and diagnosis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/537.html" rel="external">
          "Occupational asthma: Definitions, epidemiology, causes, and risk factors"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/550.html" rel="external">
          "Occupational asthma: Clinical features, evaluation, and diagnosis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/15718.html" rel="external">
          "Occupational asthma: Management, prognosis, and prevention"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          DEFINITIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Irritant-induced asthma (IIA) is a general (umbrella) term to describe an asthma-like syndrome that results from a single or multiple high dose exposures to irritant products [
         <a href="#rid3">
          3,10
         </a>
         ]. The rapid onset of asthma within a few hours after a single exposure to very high levels of irritant substances (ie, acute-onset IIA or reactive airways dysfunction syndrome [RADS]) is the phenotype of IIA that has been the best characterized. Other clinical phenotypes such as "low-dose reactive airways dysfunction syndrome," "not-so-sudden IIA," or "IIA with latency" are mainly described in epidemiologic studies because the causal relationship with irritant exposures at the workplace and occurrence of respiratory symptoms is difficult to establish at the individual level [
         <a href="#rid11">
          11-15
         </a>
         ]. When IIA is caused by workplace exposures, it is considered a type of occupational asthma (the nonimmunologic type).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acute onset IIA
         </strong>
         – Acute onset IIA is described as the development of respiratory symptoms in the minutes or hours after a single accidental inhalation of a high concentration of irritant gas, aerosol, vapor, or smoke; these initial symptoms are followed by asthma-like symptoms and airway hyperresponsiveness that persist for a prolonged period  (
         <a class="graphic graphic_table graphicRef77064" href="/z/d/graphic/77064.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid1">
          1,3
         </a>
         ]. Acute IIA can occur after exposure to a variety of chemicals generated as gas or aerosol, or exposure to high levels of particulates  (
         <a class="graphic graphic_table graphicRef55545" href="/z/d/graphic/55545.html" rel="external">
          table 2
         </a>
         ). Clinical and functional criteria for the diagnosis of acute IIA are listed in the table  (
         <a class="graphic graphic_table graphicRef77064" href="/z/d/graphic/77064.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid1">
          1,3
         </a>
         ]. IIA can be caused by multiple exposures to high doses of irritants which induce acute symptoms requiring acute medical care [
         <a href="#rid16">
          16
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Subacute IIA
         </strong>
         – The term "sub-acute IIA" has been proposed to describe instances of multiple high exposures to irritants where the onset of symptoms may be more insidious, as seen following the World Trade Center catastrophe [
         <a href="#rid8">
          8,9
         </a>
         ], or less well-documented exposures in which the affected individuals are able to identify the timing, nature, and frequency of events [
         <a href="#rid10">
          10,17
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Low-dose IIA
         </strong>
         – IIA may also include a condition resulting from multiple exposures to low concentrations of an irritant that have led to bronchial mucosal injury and persistent asthma-like symptoms, although this is less well-established [
         <a href="#rid11">
          11
         </a>
         ]. The term "low-dose IIA" (also called low-dose RADS) has been used to describe individuals in the latter group, but the pattern of repeated low-dose (as opposed to a single high-dose) exposure means that they do not formally fulfill the original criteria for acute IIA. In addition, when the intensity of the exposure is less, but is of greater duration (eg, &gt;24 hours), symptoms may start after several hours or days, rather than within minutes of inhalation, thus further "widening the spectrum of IIA" [
         <a href="#rid12">
          12
         </a>
         ]. However, "low-dose IIA" cannot currently be reliably diagnosed in an individual worker. The term Low Intensity Chronic Exposure Dysfunction Syndrome (LICEDS) has also been suggested to describe this form of IIA [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         A position paper from the European Association of Allergy and Clinical Immunology has proposed definitions for different IIA phenotypes [
         <a href="#rid3">
          3
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Definite IIA relates to acute-onset IIA manifested by rapid onset of asthma within 24 hours of a single very high-intensity exposure to an irritant compound (similar to the classic RADS phenotype).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Probable IIA is characterized by the development of asthma following multiple symptomatic moderate-high level exposures to irritants.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Possible IIA describes a delayed development of asthma following chronic and/or repeated exposure to low-moderate levels of irritant substances.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Acute IIA may occur after inhalational accidents at home, in the workplace, or in the general environment. IIA due to multiple exposures is most commonly associated with inhaled irritants in the workplace. It is estimated that 60,000 inhalational accidents occur in the home and lead to medical consultation yearly in the United States [
         <a href="#rid18">
          18
         </a>
         ]. Industrial accidents also have the potential to expose nonemployees to noxious inhalants; the release of isocyanates at Bhopal, for example, led to more than 2000 deaths due to pulmonary edema, and caused acute IIA in many others [
         <a href="#rid19">
          19,20
         </a>
         ].
        </p>
        <p>
         Estimating the incidence of acute IIA is difficult for several reasons. Precise, subject-specific information regarding the duration and magnitude of exposure at the time of an accident is rarely available. This is further complicated in IIA, where multiple exposures to irritant products are involved; the level of exposure to the inhaled irritant can vary between exposures and between exposed subjects; and several irritant agents can also be involved simultaneously [
         <a href="#rid21">
          21,22
         </a>
         ]. The size of populations at risk after an incident can only be determined approximately in many cases.
        </p>
        <p>
         The following observations, in which large numbers of patients were exposed to a chemical irritant, illustrate the variation in reported rates of development of IIA:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         After an accidental exposure to high concentrations of glacial acetic acid, the incidence of acute IIA among 51 hospital employees who were present during the 2.5 hours immediately following the accident was 16 percent [
         <a href="#rid23">
          23
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Among 289 workers exposed to chlorine gas in a pulp and paper mill, 71 (25 percent) developed respiratory symptoms shortly after the event [
         <a href="#rid24">
          24
         </a>
         ]. Among 239 workers with repeated exposures to chlorine and other gases over a three-year period, significant respiratory symptoms were reported by 38 (16 percent) [
         <a href="#rid22">
          22
         </a>
         ]. No association between exposure level and persistence of symptoms was documented. Subsequently, a longitudinal follow-up of the same workers over a three-year period showed: (1) an effect on airway function related to the estimated number of symptomatic exposures and incidents, mostly among smokers; (2) a detectable increase in airway responsiveness associated with gassing incidents [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Professional cleaning is considered a high risk occupation for work-related asthma based on studies conducted in Europe and in the United States [
         <a href="#rid26">
          26-28
         </a>
         ]. Among 123 cases of work-related IIA reported in a sentinel notification program in four states in the United States, cleaning agents were the most common reported implicated agent (15 percent) [
         <a href="#rid29">
          29
         </a>
         ]. Some epidemiologic studies have supported the role of repeated and/or chronic exposure to lower levels of cleaning agents in the development of asthma in workers exposed to those agents [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Cleaning agents may also cause occupational asthma by a mechanism of sensitization. More frequent atopy and higher levels of total IgE are found in these workers [
         <a href="#rid31">
          31
         </a>
         ]. In a group of 44 workers with symptoms on exposure to cleaning agents, 17 (39 percent) were found to have immunological occupational asthma [
         <a href="#rid32">
          32
         </a>
         ]. Asthmatic symptoms are also associated to the domestic use of cleaning agents [
         <a href="#rid33">
          33,34
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Approximately 15 percent of all cases of occupational asthma accepted for compensation in Ontario, Canada, were of the acute IIA type [
         <a href="#rid35">
          35
         </a>
         ]; a similar proportion (14 percent) was found in a sentinel notification program in four states in the United States [
         <a href="#rid29">
          29
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A number of studies have assessed the effects of exposure to the plume of particulate dust and smoke due to the fires and structural collapse of the World Trade Center towers on September 11, 2001 [
         <a href="#rid8">
          8,9,36,37
         </a>
         ]. The rate of newly diagnosed asthma among workers and volunteers was almost 4 percent and correlated with an earlier time of arrival and greater duration of time at the site [
         <a href="#rid36">
          36,38
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Exposure to a low/moderate level of irritants has been shown to be associated with the diagnosis of asthma (OR 1.88, 95% CI 1.48-2.37) [
         <a href="#rid39">
          39
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H31976583">
         <span class="h1">
          CAUSES AND RISK FACTORS
         </span>
         <span class="headingEndMark">
          —
         </span>
         A number of agents have been implicated in the development of IIA, most commonly chlorine, isocyanates, oxides of nitrogen, acetic acid, and sulphur dioxide  (
         <a class="graphic graphic_table graphicRef55545" href="/z/d/graphic/55545.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid40">
          40,41
         </a>
         ]. As an example, one study identified 46 different agents as having caused occupational irritant-induced asthma, associated with apparently high concentration exposures without a latency period [
         <a href="#rid42">
          42
         </a>
         ]. A separate study reported that paper, metal and chemical industries were responsible for the majority of their cases of IIA. Cases of acute IIA were related to accidents whereas subacute IIA occurred mainly among industrial operators performing usual work tasks with poor hygiene conditions [
         <a href="#rid43">
          43
         </a>
         ].
        </p>
        <p>
         Definitive risk factors for the development of IIA have not been confirmed, but probable risk factors likely include the chemical and physical nature and concentration of the irritant agent in addition to certain host factors such as atopy and cigarette smoking.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          High concentration exposure
         </strong>
         – Increased concentrations of offending agents are associated with higher risk, and vapors and wet aerosols generally appear to be more provocative of acute IIA than dry particulates [
         <a href="#rid23">
          23,44
         </a>
         ]. Workers exposed to bleaching agents in paper mills (including chlorine) [
         <a href="#rid45">
          45
         </a>
         ] and cleaning products [
         <a href="#rid27">
          27,44
         </a>
         ] are particularly at risk. Excess rates of asthma have been documented in workers exposed to cleaning agents, and IIA may explain this phenomenon  (
         <a class="graphic graphic_table graphicRef55545" href="/z/d/graphic/55545.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid46">
          46
         </a>
         ]. The main risk factor for developing respiratory diseases identified among the World Trade Center (WTC) rescue workers was the presence on the site of the WTC during the first 48 hours and the duration of exposure during rescue [
         <a href="#rid47">
          47
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Atopy
         </strong>
         – While atopy has been described as a risk factor for the occurrence of the not-so-sudden-onset variant of IIA that develops days after an irritant exposure [
         <a href="#rid12">
          12
         </a>
         ], there is no evidence that atopy is a risk factor for the development of IIA [
         <a href="#rid23">
          23,24,48
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Airway hyperresponsiveness
         </strong>
         – Previously documented airway hyperresponsiveness did not predispose to the development of acute IIA in firefighters at the World Trade Center [
         <a href="#rid49">
          49
         </a>
         ]. It is likely that the pre-existing airway hyperresponsiveness was infrequent among these firefighters given that asthma is an exclusion criterion for recruitment. However, lifetime prevalence of asthma was increased in WTC responders by comparison with a large control population [
         <a href="#rid50">
          50
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Smoking
         </strong>
         – Smoking is more common among workers with acute IIA than in those with other types of occupational asthma and seems to increase the risk of functional decline in workers repeatedly exposed to puffs of chlorine [
         <a href="#rid25">
          25,35
         </a>
         ]. However, some studies have suggested that the development of acute and sub-acute IIA was not associated with smoking [
         <a href="#rid23">
          23,24
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Genetic factors
         </strong>
         – Although some observations suggest a possible genetic predisposition to be more susceptible to the effects of irritants, as for sensitizing agents, this remains to be further examined [
         <a href="#rid51">
          51
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4798536">
         <span class="h1">
          PATHOLOGY AND MECHANISMS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Serial observations from two cases of acute IIA illustrate the histopathologic features of the disease  (
         <a class="graphic graphic_table graphicRef78151" href="/z/d/graphic/78151.html" rel="external">
          table 3
         </a>
         ) [
         <a href="#rid52">
          52,53
         </a>
         ]. The initial change was rapid denudation of the mucosa with a fibrinohemorrhagic exudate in the submucosa. This was followed by subepithelial edema and signs of regeneration of the epithelial layer with proliferation of basal and parabasal cells. Desquamation, subepithelial fibrosis, thickening of the reticular basement membrane, and regeneration of basal cells are all more striking in acute IIA than in occupational asthma with a latency period  (
         <a class="graphic graphic_table graphicRef80475" href="/z/d/graphic/80475.html" rel="external">
          table 4
         </a>
         ). In addition, bronchoalveolar lavage (BAL) reveals neutrophilia in acute IIA, whereas lymphocytes and eosinophils are more numerous in occupational asthma with a latency period. (See
         <a class="medical medical_review" href="/z/d/html/538.html" rel="external">
          "Occupational asthma: Pathogenesis", section on 'Pathology'
         </a>
         .)
        </p>
        <p>
         The histopathologic changes seen in acute IIA have been reproduced by exposing rats to high concentrations of gaseous chlorine [
         <a href="#rid54">
          54
         </a>
         ]. Histologic evaluation revealed epithelial flattening, necrosis, and evidence of epithelial regeneration. Bronchoalveolar lavage showed an increased number of neutrophils. Abnormalities in epithelial pathology and bronchial hyperresponsiveness were most prominent one to three days following injury. Epithelial abnormalities persisted in some animals for up to three months [
         <a href="#rid54">
          54
         </a>
         ]. Similar findings have been described in a mouse model of acute IIA [
         <a href="#rid55">
          55
         </a>
         ]. Chlorine can induce direct oxidative epithelium injury, but further damage may also occur with migration and activation of inflammatory cells such as neutrophils within the airway epithelium, with subsequent release of reactive oxygen species and proteolytic enzymes. In a mouse model, airway barrier impairment led to the development of airway hypersensitivity after low-dose chlorine exposure [
         <a href="#rid56">
          56
         </a>
         ], suggesting that airway epithelial damage may be a risk factor for developing IIA after exposure to irritant agents.
        </p>
        <p>
         The release of reactive oxygen species can contribute to airflow limitation and airway hyperreactivity [
         <a href="#rid57">
          57
         </a>
         ]. In a separate study, an antioxidant preparation diminished many features of tissue damage following exposure to chlorine gas, including the increase in BAL neutrophils and macrophages [
         <a href="#rid58">
          58
         </a>
         ].
        </p>
        <p>
         The long term (approximately 10 years) pathological abnormalities of acute IIA have been described [
         <a href="#rid59">
          59
         </a>
         ]. Bronchial biopsies obtained from 10 subjects with IIA at a mean of 10 years following an industrial accident showed neutrophilic and eosinophilic inflammation [
         <a href="#rid59">
          59
         </a>
         ]. In addition, reticular basement membranes were thicker among patients with acute IIA than those with mild immunologic occupational asthma or healthy controls.
        </p>
        <p>
         In one patient with subacute IIA secondary to multiple exposures, an inflammatory infiltrate consisting of lymphocytes and polymorphonuclear cells was found on bronchial biopsy [
         <a href="#rid16">
          16
         </a>
         ]. In the chronic stage of irritant-induced asthma, the infiltrate consisted of lymphocytes and eosinophils, with thickening of connective tissue and deposition of collagen fibers [
         <a href="#rid16">
          16,60
         </a>
         ].
        </p>
        <p>
         In a cross-sectional study of 999 adults, occupational exposure to irritants was associated with a specific respiratory endotype, suggesting that oxidative stress and neutrophilic inflammation were potentially associated biological mechanisms [
         <a href="#rid61">
          61
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          History
         </strong>
         – The clinical manifestations (eg, cough, dyspnea, wheeze, chest tightness) of acute and not-so-sudden onset variants of IIA differ mainly in the rapidity of onset of symptoms.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The onset of symptoms in acute IIA is usually so abrupt that subjects are able to date their occurrence precisely, although a few patients report respiratory symptoms developing up to seven days after the exposure [
         <a href="#rid17">
          17,62
         </a>
         ]. Patients with multiple exposures to high concentrations of products such as chlorine may be able to identify the timing, nature, and frequency of most events [
         <a href="#rid10">
          10,17
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Patients with the not-so-sudden onset variant of IIA may not be aware of multiple low level irritant exposures and may report episodic symptoms that are not precisely linked to known exposures.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         After an acute exposure to gas, smoke, fumes, or vapors with irritant properties, some subjects with no history of respiratory complaints report a burning sensation in the throat and nose referred to as respiratory upper airways distress syndrome (RUDS) [
         <a href="#rid63">
          63
         </a>
         ], in addition to cough, dyspnea, wheeze, and chest pain [
         <a href="#rid1">
          1,23,64
         </a>
         ]. These symptoms typically develop within 24 hours of the exposure and are severe enough that approximately 78 percent seek emergency room treatment [
         <a href="#rid29">
          29
         </a>
         ]. In most series, cough is the predominant symptom in IIA [
         <a href="#rid1">
          1,65,66
         </a>
         ]. (See
         <a class="local">
          'Definitions'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Patients with subacute IIA due to multiple low-level exposures to irritant agents describe essentially the same symptoms as patients with acute IIA (eg, cough, dyspnea, chest tightness, and wheezing), although the time course of onset differs. Symptoms of nasal mucosal irritation, such as nasal congestion, sneezing, nasal pruritus and/or increased nasal secretions, may accompany the asthma-like symptoms and are often exacerbated by recurrent exposure in the workplace [
         <a href="#rid67">
          67
         </a>
         ]. Occupational rhinitis is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/7529.html" rel="external">
          "Occupational rhinitis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Physical examination
         </strong>
         – Physical examination findings are not well described, but have included conjunctivitis, pharyngeal erythema, tearing, tachypnea, and wheezing [
         <a href="#rid24">
          24,68
         </a>
         ]. After an accidental chlorine exposure, 67 percent (42 of 63) had wheezing on initial presentation, and 84 percent had wheezing at some point in their hospitalization [
         <a href="#rid64">
          64
         </a>
         ]. Exposure to ammonia may be associated with burns and blisters on exposed skin and damage to the surface structures of the eye. (See
         <a class="medical medical_review" href="/z/d/html/345.html" rel="external">
          "Topical chemical burns: Initial evaluation and management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4797885">
         <span class="h1">
          EVALUATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         IIA should be suspected in patients with asthma-like symptoms following a well-defined exposure. An important component of the evaluation is to review the details of the history, particularly when the patient is seen weeks or months after the initial exposure. Some relevant questions to be asked to all subjects when first assessed for possible asthma, and particularly for IIA, are listed in the table  (
         <a class="graphic graphic_table graphicRef68098" href="/z/d/graphic/68098.html" rel="external">
          table 5
         </a>
         ).
        </p>
        <p>
         The evaluation of a patient with the acute onset of respiratory symptoms following an irritant exposure typically includes assessment of oxygenation by pulse oximetry or arterial blood gases and a chest radiograph to look for noncardiogenic pulmonary edema, pneumonia, or other causes of dyspnea. As soon as possible, spirometry should be performed to determine whether airflow limitation is present and reversible. (See
         <a class="medical medical_review" href="/z/d/html/292.html" rel="external">
          "Approach to the adult with dyspnea in the emergency department"
         </a>
         .)
        </p>
        <p>
         For patients with persistent symptoms due to IIA, the evaluation is the same for the two processes. In addition to spirometry, testing includes more complete pulmonary function testing with assessment of nonspecific hyperresponsiveness. An approach to the patient with dyspnea is provided separately. (See
         <a class="medical medical_review" href="/z/d/html/1436.html" rel="external">
          "Approach to the patient with dyspnea"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4798684">
         <span class="h2">
          Laboratory testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         Routine laboratory testing is usually not helpful in the diagnosis of irritant exposures. However, a complete blood count and differential are appropriate to help exclude other processes in the differential diagnosis of dyspnea such as anemia, eosinophilic pneumonia, and infection.
        </p>
        <p class="headingAnchor" id="H4798305">
         <span class="h2">
          Skin and immunologic testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients with chronic symptoms due to IIA, either allergy skin testing or immunoassay to a panel of common aeroallergens is appropriate to exclude allergic asthma due to common aeroallergens or a sensitizing process evocating immunologic occupational asthma. (See
         <a class="medical medical_review" href="/z/d/html/5541.html" rel="external">
          "Overview of skin testing for IgE-mediated allergic disease"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5540.html" rel="external">
          "Overview of in vitro allergy tests"
         </a>
         .)
        </p>
        <p>
         In vitro immunoassay for IgE antibodies to occupational sensitizers is available for a limited number of low molecular weight chemical-protein conjugates (eg, diisocyanates), but these are not standardized or commercially available. An acute increase in specific IgE antibodies to formaldehyde has been described in a case of acute IIA associated with high level exposure to formaldehyde, although the significance of this observation is not known [
         <a href="#rid69">
          69
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4797893">
         <span class="h2">
          Pulmonary function testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         One of the first steps in the evaluation of a patient with respiratory symptoms after an irritant inhalational exposure is pulmonary function testing to assess the presence, severity, and reversibility of airflow limitation. For patients without significant airflow obstruction, bronchoprovocation challenge can be used to document non-specific airways hyperresponsiveness. The roles of spirometry and bronchoprovocation challenge in the diagnosis of asthma are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/569.html" rel="external">
          "Pulmonary function testing in asthma", section on 'Tests for the diagnosis of asthma'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/525.html" rel="external">
          "Bronchoprovocation testing"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4798231">
         <span class="h3">
          Spirometry
         </span>
         <span class="headingEndMark">
          —
         </span>
         Baseline spirometry is obtained in all patients suspected of having IIA; bronchodilator reversibility is assessed if airflow limitation is present. In a series of 19 patients seen after chlorine exposure, 10 had airflow limitation when assessed soon after the exposure; many showed reversal of obstruction with time [
         <a href="#rid70">
          70
         </a>
         ]. In a separate study of 10 subjects with acute IIA due to high level exposures to a variety of agents, four had airflow obstruction with a forced expiratory volume in one second/forced vital capacity (FEV
         <sub>
          1
         </sub>
         /FVC) ratio &lt;70 percent [
         <a href="#rid1">
          1
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6968.html" rel="external">
          "Office spirometry"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/569.html" rel="external">
          "Pulmonary function testing in asthma", section on 'Tests for the diagnosis of asthma'
         </a>
         .)
        </p>
        <p>
         Following baseline spirometry, bronchodilator reversibility is assessed by inhalation of a short-acting beta-agonist. In general, reversibility is defined as a postbronchodilator increase in FEV
         <sub>
          1
         </sub>
         by more than 10 percent of its predicted value [
         <a href="#rid71">
          71
         </a>
         ]. Airway obstruction is generally less responsive to a bronchodilator in acute IIA than in asthma, although some degree of reversibility may be present. A comparison of 30 subjects with immunologic occupational asthma and 15 subjects with acute IIA found a mean improvement in FEV
         <sub>
          1
         </sub>
         after bronchodilator of close to 20 percent in the subjects with immunologic occupational asthma, nearly double the response seen among those with acute IIA. However, significant heterogeneity was seen among the acute IIA group: 6 of the 15 subjects had a postbronchodilator improvement in FEV
         <sub>
          1
         </sub>
         of more than 15 percent [
         <a href="#rid22">
          22
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/569.html" rel="external">
          "Pulmonary function testing in asthma", section on 'Bronchodilator responses'
         </a>
         .)
        </p>
        <p>
         In a minority of patients, a restrictive defect is noted on pulmonary function testing, although an obstructive pattern is much more common [
         <a href="#rid72">
          72
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6969.html" rel="external">
          "Overview of pulmonary function testing in adults", section on 'Lung volumes'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4798224">
         <span class="h3">
          Nonspecific bronchoprovocation challenge
         </span>
         <span class="headingEndMark">
          —
         </span>
         If baseline spirometry shows absent or minimal airflow limitation and no significant bronchodilator reversibility, nonspecific (or nonallergic) bronchial challenge (eg,
         <a class="drug drug_general" data-topicid="9622" href="/z/d/drug information/9622.html" rel="external">
          methacholine
         </a>
         ) is performed to assess for non-specific bronchial hyperresponsiveness. The performance of bronchoprovocation challenge, contraindications to testing, and adjustments of medication prior to testing, are described separately. (See
         <a class="medical medical_review" href="/z/d/html/525.html" rel="external">
          "Bronchoprovocation testing"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/525.html" rel="external">
          "Bronchoprovocation testing", section on 'Pharmacologic challenge'
         </a>
         .)
        </p>
        <p>
         Among various case reports, a positive bronchoprovocation challenge was present at initial evaluation in virtually all patients who were able to perform the testing. (See
         <a class="medical medical_review" href="/z/d/html/569.html" rel="external">
          "Pulmonary function testing in asthma", section on 'Bronchodilator responses'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4798276">
         <span class="h3">
          Specific bronchoprovocation challenge
         </span>
         <span class="headingEndMark">
          —
         </span>
         Specific inhalation challenges are not performed to diagnose IIA with agents that are known to cause IIA [
         <a href="#rid2">
          2
         </a>
         ]. The majority of these agents are not sensitizers and would not induce an acute asthmatic reaction when inhaled at low levels for a short period of time. (See
         <a class="medical medical_review" href="/z/d/html/550.html" rel="external">
          "Occupational asthma: Clinical features, evaluation, and diagnosis", section on 'Specific inhalation challenge'
         </a>
         .)
        </p>
        <p>
         However, rare individuals can experience acute IIA after exposure to agents that have both irritant and sensitizing properties (eg, isocyanates) and subsequently develop occupational asthma. For example, a subject developed occupational asthma while exposed to lower levels of diisocyanates after an initial high exposure to this agent that induced acute IIA [
         <a href="#rid73">
          73
         </a>
         ]. In this instance, performing specific inhalation was useful to confirm the diagnosis of occupational asthma. (See
         <a class="medical medical_review" href="/z/d/html/537.html" rel="external">
          "Occupational asthma: Definitions, epidemiology, causes, and risk factors", section on 'Low-molecular-weight'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/550.html" rel="external">
          "Occupational asthma: Clinical features, evaluation, and diagnosis", section on 'Specific inhalation challenge'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4798648">
         <span class="h2">
          Imaging
         </span>
         <span class="headingEndMark">
          —
         </span>
         A chest radiograph is typically obtained to exclude noncardiogenic pulmonary edema, alveolitis, or pneumonia in patients presenting after an acute irritant exposure or other causes of dyspnea in those presenting later in the course of acute IIA or after multiple lower dose irritant exposures. The chest radiograph in patients with IIA is typically normal or may show hyperinflation. (See
         <a class="medical medical_review" href="/z/d/html/292.html" rel="external">
          "Approach to the adult with dyspnea in the emergency department", section on 'Plain chest radiograph'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1436.html" rel="external">
          "Approach to the patient with dyspnea", section on 'Chest computed tomography'
         </a>
         .)
        </p>
        <p>
         High-resolution computed tomography (HRCT) is not required in the evaluation of IIA but may be performed in atypical cases to exclude alternative diagnoses. HRCT scans, obtained in 29 symptomatic rescue and recovery workers at the World Trade Center site, showed evidence of air-trapping based on a mosaic pattern on the end-expiratory images in 25 of these workers [
         <a href="#rid74">
          74
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of IIA is based upon a combination of exposure history  (
         <a class="graphic graphic_table graphicRef68098" href="/z/d/graphic/68098.html" rel="external">
          table 5
         </a>
         ), time course of symptom onset, and evidence of reversible airflow limitation and/or non-specific bronchial hyperresponsiveness.
        </p>
        <p>
         The diagnosis of acute IIA is likely in individuals with:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A history of acute exposure to an irritant agent or material preceding the onset of respiratory symptoms (see
         <a class="local">
          'Clinical manifestations'
         </a>
         above)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Acute onset of respiratory symptoms within 24 hours of the exposure, or within seven days at the latest (see
         <a class="local">
          'Clinical manifestations'
         </a>
         above)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Persistence of airway obstruction and/or hyperresponsiveness, generally for three months or more (see
         <a class="local">
          'Pulmonary function testing'
         </a>
         above)
        </p>
        <p>
        </p>
        <p>
         The diagnosis of subacute IIA is often not as straightforward as the diagnosis of acute IIA due to the lack of a single episode of high-level exposure. However, a history of single or multiple exposures to an irritating inhalational agent  (
         <a class="graphic graphic_table graphicRef68098" href="/z/d/graphic/68098.html" rel="external">
          table 5
         </a>
         ), the presence of asthma-like symptoms, and the presence of reversible airway obstruction and/or hyperresponsiveness are necessary to the diagnosis. (See
         <a class="local">
          'Pulmonary function testing'
         </a>
         above.)
        </p>
        <p>
         The absence of specific testing that can establish a causal role of an irritant agent makes it difficult to establish the diagnosis of IIA with certainty. However, data from epidemiologic studies that have identified occupations with an increased risk of asthma, such as cleaners [
         <a href="#rid46">
          46,75
         </a>
         ] and pulp mill workers [
         <a href="#rid45">
          45
         </a>
         ], can be used to support a diagnosis of IIA in a patient with similar exposures [
         <a href="#rid21">
          21
         </a>
         ] (see
         <a class="local">
          'Epidemiology'
         </a>
         above). However, distinguishing IIA caused by repeated, moderate or low level exposures from coincidental non-work related asthma is very difficult and often impossible on a clinical basis.
        </p>
        <p class="headingAnchor" id="H361579">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
        </p>
        <p class="headingAnchor" id="H18301455">
         <span class="h2">
          Acute presentation
         </span>
         <span class="headingEndMark">
          —
         </span>
         At the time of an acute presentation with IIA, the differential diagnosis includes the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Underlying asthma that may have been exacerbated by an irritant exposure
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Acute respiratory infection
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cardiogenic or noncardiogenic pulmonary edema
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other causes of an acute onset of dyspnea
        </p>
        <p>
        </p>
        <p>
         A careful history provides guidance regarding the severity of the exposure and thus the likelihood of acute IIA versus an exacerbation of underlying asthma. A conventional chest radiograph can help exclude pneumonia, pulmonary edema, and acute eosinophilic pneumonia. A complete blood count and differential provides supportive information for or against infectious or eosinophilic pneumonia. (See
         <a class="medical medical_review" href="/z/d/html/543.html" rel="external">
          "Asthma in adolescents and adults: Evaluation and diagnosis", section on 'Diagnosis'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6870.html" rel="external">
          "Acute bronchitis in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7032.html" rel="external">
          "Clinical evaluation and diagnostic testing for community-acquired pneumonia in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/292.html" rel="external">
          "Approach to the adult with dyspnea in the emergency department"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H18301462">
         <span class="h2">
          Persistent symptoms
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients presenting with persistent symptoms, the differential diagnosis of IIA typically includes underlying asthma that may have been exacerbated by an irritant exposure, occupational asthma due to an immunologic reaction to an agent in the workplace, paradoxical motion of the vocal cord (also known as vocal cord dysfunction or irritable larynx syndrome), and nonasthmatic eosinophilic bronchitis as well as other causes mimicking asthma.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pre-existing asthma
         </strong>
         – A history of prior symptoms of cough or dyspnea, possibly exacerbated by respiratory infection or exposure to irritants, favors a diagnosis of pre-existing asthma.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Occupational asthma
         </strong>
         – A number of features are common to IIA and immunologic occupational asthma. Wheezing and airflow obstruction are common to both conditions. A differentiating feature is that immunologic occupational asthma is reproduced by inhalation challenge with low levels of the offending workplace agent, while IIA is not  (
         <a class="graphic graphic_table graphicRef80475" href="/z/d/graphic/80475.html" rel="external">
          table 4
         </a>
         ). Differentiation may also be based on the type of exposure. As an example, exposure to chlorine and cleaning agents is associated with IIA [
         <a href="#rid28">
          28,76
         </a>
         ], while exposure to flour and latex is associated with occupational asthma. A few of these agents, however, have been associated with both syndromes (eg, diisocyanates, cleaning agents). (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above and
         <a class="local">
          'Pulmonary function testing'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/550.html" rel="external">
          "Occupational asthma: Clinical features, evaluation, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/537.html" rel="external">
          "Occupational asthma: Definitions, epidemiology, causes, and risk factors", section on 'Causative agents'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Paradoxical vocal fold motion
         </strong>
         – Paradoxical vocal fold motion (PVFM) refers to abnormal closure of the vocal cords, usually on inspiration; it may mimic asthma or accompany asthma. A temporal association of onset of PVFM and irritant exposure has been described, adding to the importance of differentiating these entities [
         <a href="#rid77">
          77
         </a>
         ]. The diagnosis of PVFM is usually suggested by the presence of dysphonia and abnormal slowing of the inspiratory flow volume loop obtained during routine spirometry or nonspecific bronchoprovocation challenge. The diagnosis is confirmed by direct visualization of the vocal cords by laryngoscopy. (See
         <a class="medical medical_review" href="/z/d/html/523.html" rel="external">
          "Inducible laryngeal obstruction (paradoxical vocal fold motion)", section on 'Evaluation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/525.html" rel="external">
          "Bronchoprovocation testing", section on 'Pharmacologic challenge'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Nonasthmatic eosinophilic bronchitis
         </strong>
         – Nonasthmatic eosinophilic bronchitis (NAEB) is characterized by a cough that is usually nonproductive, eosinophilia in induced sputum, and the absence of airflow limitation or bronchial hyperresponsiveness. NAEB has been described in workers exposed to a variety of occupational agents that are associated with IgE-mediated sensitization [
         <a href="#rid2">
          2,78-80
         </a>
         ]. The key differentiating feature is the negative non-specific bronchoprovocation challenge among patients with NAEB. While induced sputum shows eosinophilia in NAEB, induced sputum analysis has not been fully evaluated in IIA and is not widely available. (See
         <a class="local">
          'Nonspecific bronchoprovocation challenge'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/1460.html" rel="external">
          "Causes and epidemiology of subacute and chronic cough in adults", section on 'Nonasthmatic eosinophilic bronchitis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h1">
          TREATMENT
         </span>
        </p>
        <p class="headingAnchor" id="H92154380">
         <span class="h2">
          Management of acute irritant-induced asthma
         </span>
         <span class="headingEndMark">
          —
         </span>
         The management of acute IIA is essentially the same as the treatment of an acute asthma exacerbation [
         <a href="#rid60">
          60
         </a>
         ]. However, the optimal treatment of this condition has never been assessed prospectively in a clinical trial. (See
         <a class="medical medical_review" href="/z/d/html/119093.html" rel="external">
          "Acute exacerbations of asthma in adults: Emergency department and inpatient management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/528.html" rel="external">
          "Acute exacerbations of asthma in adults: Home and office management"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Bronchodilators
         </strong>
         – Bronchodilator therapy is administered based on the severity of symptoms and response to treatment, even though the response to inhaled bronchodilator may be blunted in acute IIA compared with asthma. If a short-acting beta-agonist (SABA) does not provide adequate symptomatic relief, we typically add
         <a class="drug drug_general" data-topicid="8570" href="/z/d/drug information/8570.html" rel="external">
          ipratropium
         </a>
         , although data in support of this are limited.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Systemic glucocorticoids
         </strong>
         – Treatment of acute IIA includes prompt administration of systemic glucocorticoids (eg,
         <a class="drug drug_general" data-topicid="9809" href="/z/d/drug information/9809.html" rel="external">
          prednisone
         </a>
         40 to 60 mg daily) for patients with moderate to severe symptoms and a forced expiratory volume in one second (FEV
         <sub>
          1
         </sub>
         ) less than 70 percent predicted. No formal trials have been performed on glucocorticoid therapy in acute IIA, so the use of systemic glucocorticoids for acute IIA is based upon clinical experience and their well-documented role in asthma [
         <a href="#rid52">
          52,53
         </a>
         ]. Support for systemic glucocorticoid therapy comes from their use in an animal model of IIA. Parenteral glucocorticoids, given for one week immediately after exposure, significantly attenuated expected increases in lung resistance and bronchial hyperresponsiveness; bronchoalveolar lavage (BAL) and histologic parameters were likewise improved [
         <a href="#rid54">
          54
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         We typically continue oral
         <a class="drug drug_general" data-topicid="9809" href="/z/d/drug information/9809.html" rel="external">
          prednisone
         </a>
         for 10 to 15 days, which is longer than that used for typical exacerbations of asthma, as it is our clinical observation that patients improve slowly and do not tolerate tapering sooner. High-dose inhaled glucocorticoids (eg,
         <a class="drug drug_general" data-topicid="8951" href="/z/d/drug information/8951.html" rel="external">
          fluticasone
         </a>
         propionate 1000 mcg/day or the equivalent), with or without concomitant inhaled long-acting beta-2 agonist, are also started to help control asthma symptoms developing upon tapering of prednisone. Relatively high doses of inhaled glucocorticoids may be required for long-term treatment as pathological evidence shows the persistence of eosinophils [
         <a href="#rid59">
          59
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Inhaled glucocorticoids
         </strong>
         – For patients who have a documented irritant exposure but whose initial symptoms and airflow obstruction are less severe (eg, FEV
         <sub>
          1
         </sub>
         ≥70 percent predicted), we suggest initiation of inhaled glucocorticoids rather than systemic glucocorticoids or inhaled beta agonist therapy alone. Data in support of inhaled glucocorticoids are limited, but a case report of a subject with acute IIA reflects our experience. In the report, treatment with inhaled glucocorticoids normalized bronchial hyperresponsiveness, but hyperresponsiveness worsened when therapy was stopped [
         <a href="#rid53">
          53
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The initial dose of inhaled glucocorticoids is based on the step-wise approach to asthma outlined in the Global Initiative for Asthma (GINA) [
         <a href="#rid81">
          81
         </a>
         ]; in our experience the majority of patients require a high dose to control symptoms  (
         <a class="graphic graphic_table graphicRef78011" href="/z/d/graphic/78011.html" rel="external">
          table 6
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/547.html" rel="external">
          "An overview of asthma management", section on 'Initiating therapy in previously untreated patients'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Once patients have demonstrated symptomatic improvement, inhaled glucocorticoids can be tapered as tolerated. Airflow limitation is assessed serially with spirometry as the inhaled glucocorticoids are tapered. If asthma has remained well-controlled for several weeks and the FEV
         <sub>
          1
         </sub>
         is stable, then the inhaled glucocorticoids are decreased by 25 to 50 percent increments. When the FEV
         <sub>
          1
         </sub>
         is greater than 70 percent of predicted, bronchial responsiveness to
         <a class="drug drug_general" data-topicid="9622" href="/z/d/drug information/9622.html" rel="external">
          methacholine
         </a>
         may be used to guide tapering inhaled glucocorticoids, although this approach is not well-validated. The weaning of inhaled glucocorticoids may take six weeks to six months, and many patients require more long-term therapy. (See
         <a class="local">
          'Prognosis'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H92154406">
         <span class="h2">
          Chronic management of irritant-induced asthma
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients with IIA who require long-term pharmacologic treatment for asthma symptoms, the step-wise approach described in the Global Initiative for Asthma (GINA) guidelines is followed even though it has not been formally assessed in this setting [
         <a href="#rid81">
          81
         </a>
         ]. Over time, if the patient's asthma remains well-controlled, therapy is tapered according to the same guidelines. The long-term treatment of acute or less acute forms of IIA is the same, even though the specific timing and pattern of onset differ. (See
         <a class="medical medical_review" href="/z/d/html/547.html" rel="external">
          "An overview of asthma management", section on 'Adjusting controller medication'
         </a>
         .)
        </p>
        <p>
         Nonpharmacologic treatment of IIA has not been studied directly; however, based on clinical experience patients are advised to avoid exposure to other respiratory irritants, including cigarette smoke [
         <a href="#rid82">
          82
         </a>
         ]. For those patients who have underlying atopy, avoidance of known allergens to which they are sensitive is also appropriate. (See
         <a class="medical medical_review" href="/z/d/html/562.html" rel="external">
          "Trigger control to enhance asthma management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/530.html" rel="external">
          "Allergen avoidance in the treatment of asthma and allergic rhinitis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16634.html" rel="external">
          "Overview of smoking cessation management in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4798774">
         <span class="h1">
          EXPOSURE AVOIDANCE AND RETURNING TO WORK
         </span>
         <span class="headingEndMark">
          —
         </span>
         Unlike workers with immunologic occupational asthma, most workers with IIA can return to their working environment with proper asthma treatment as long as their asthma is well-controlled and safety measures are taken to avoid unintentional high-level exposures [
         <a href="#rid2">
          2,3
         </a>
         ]. Ongoing monitoring of symptoms and respiratory physiology is, however, key to early identification of any deterioration.
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h1">
          PROGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The long-term outcome of IIA is unclear as longitudinal, prospective data are limited. The available evidence suggests a range of responses from complete clearance of symptoms and signs to persistent respiratory disability [
         <a href="#rid59">
          59,65,67,83-87
         </a>
         ]. As examples:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Among 20 patients who had repeated exposures to chlorine gas during a three-month period, two-thirds still had an abnormal response to
         <a class="drug drug_general" data-topicid="9622" href="/z/d/drug information/9622.html" rel="external">
          methacholine
         </a>
         three years later, and 85 percent reported wheezing, shortness of breath, or cough [
         <a href="#rid83">
          83
         </a>
         ]. In a separate series of 71 workers suspected to have acute IIA following exposures to chlorine, 90 percent had persistent respiratory symptoms 18 to 24 months after exposure and 57 percent had bronchial hyperresponsiveness [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A population-based study of 145 subjects exposed to chlorine gas found no changes in pulmonary function testing over the six-year follow-up period; however, airway responsiveness was not assessed [
         <a href="#rid85">
          85
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a 10-year follow-up of 197 veterans of the Iran-Iraq war with acute poisoning with sulfur mustard gas, asthma symptoms, reversible airflow obstruction, and excessive diurnal peak expiratory flow variability were present in 11 percent [
         <a href="#rid86">
          86
         </a>
         ]. In addition, chronic bronchitis or bronchiectasis occurred in 68 percent of patients, presumably due to extensive bronchial necrosis following acute exposure.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Among 35 workers with IIA, almost all continued to have symptoms consistent with asthma and one-third were still using inhaled glucocorticoids at follow-up eight or more years later [
         <a href="#rid65">
          65
         </a>
         ]. Spirometry was persistently abnormal in 74 percent. Among 23 who had repeat measurements of
         <a class="drug drug_general" data-topicid="9622" href="/z/d/drug information/9622.html" rel="external">
          methacholine
         </a>
         responsiveness, nine (25 percent) were no longer hyperresponsive. Bronchial biopsies were performed in 10 subjects at a mean of 10.9 years following the initial exposure and eosinophilic inflammation similar to that found in subjects with mild to moderate asthma was noted, but with more pronounced basement membrane thickening [
         <a href="#rid59">
          59
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Among 13,954 Fire Department of New York City rescue workers present on the site of the World Trade Center in September 2001, 91.6 percent participated in a routine surveillance program. After a median of 6.1 years of follow-up, the significant decline in FEV
         <sub>
          1
         </sub>
         seen during the first year persisted without recovery [
         <a href="#rid72">
          72,88
         </a>
         ]. Greater than normal lung functions declines were associated with initial bronchodilator response and weight gain in a five year follow-up by the World Trade Center Worker and Volunteer Monitoring Program [
         <a href="#rid89">
          89
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2155635233">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/112673.html" rel="external">
          "Society guideline links: Occupational asthma"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H31975798">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definitions
         </strong>
         – IIA is a general term to describe an asthmatic syndrome that results from single or multiple exposures to irritant products  (
         <a class="graphic graphic_table graphicRef55545" href="/z/d/graphic/55545.html" rel="external">
          table 2
         </a>
         ) that induce bronchial hyperresponsiveness. When symptoms promptly follow a single high-dose exposure, the syndrome is called acute IIA (aka, reactive airways dysfunction syndrome [RADS]). (See
         <a class="local">
          'Definitions'
         </a>
         above and
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical manifestations
         </strong>
         – Symptoms associated with acute IIA include a rapid onset of a burning sensation in the throat and nose, chest pain, dyspnea, cough and wheeze. In subacute IIA, the symptoms are similar, but the onset is slower. Questions that are helpful in the evaluation of IIA are listed in the table  (
         <a class="graphic graphic_table graphicRef68098" href="/z/d/graphic/68098.html" rel="external">
          table 5
         </a>
         ). (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis of acute IIA
         </strong>
         – The diagnosis of acute IIA requires the combination of exposure to a high-dose of an inhalational irritant, onset of symptoms within hours (rarely days), and evidence of reversible airflow limitation (eg, spirometry with bronchodilator reversibility or positive non-specific bronchoprovocation challenge), although a restrictive defect can also be present. A chest radiograph is often obtained to exclude other causes of dyspnea. Criteria for the diagnosis of acute IIA are summarized in the table  (
         <a class="graphic graphic_table graphicRef77064" href="/z/d/graphic/77064.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Evaluation'
         </a>
         above and
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis of subacute IIA
         </strong>
         – The diagnosis of subacute IIA is based upon a history of single or multiple exposures to an irritating inhalational agent, the presence of asthma-like symptoms, and the presence of reversible airway obstruction and/or hyperresponsiveness. (See
         <a class="local">
          'Diagnosis'
         </a>
         above and
         <a class="local">
          'Pulmonary function testing'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Initial treatment of acute IIA
         </strong>
         – For patients who present with acute IIA, we use the same treatment approach that is used for acute asthma exacerbations in other settings, including oral glucocorticoids and inhaled glucocorticoids (aka, inhaled corticosteroids [ICS]) with or without concomitant long-acting inhaled beta-2 agonists (LABAs). In our experience, medium- or high-dose ICS-LABA combination therapy is often needed to control symptoms. Inhaled rather than oral glucocorticoids are appropriate initial therapy for patients who present with less severe symptoms. (See
         <a class="local">
          'Treatment'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/119093.html" rel="external">
          "Acute exacerbations of asthma in adults: Emergency department and inpatient management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Controller therapies for IIA
         </strong>
         – For patients with persistent symptoms due to IIA, we follow the standard stepwise approach used in asthma management. In addition, patients are advised to avoid respiratory irritants, including cigarette smoke, and allergens to which they are sensitive. (See
         <a class="local">
          'Chronic management of irritant-induced asthma'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/547.html" rel="external">
          "An overview of asthma management", section on 'Initiating pharmacologic treatment'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/562.html" rel="external">
          "Trigger control to enhance asthma management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Return to work
         </strong>
         – In general, workers with IIA are able to return to their working environment with appropriate asthma treatment and safety measures to prevent further high-dose exposures. The worker should have ongoing monitoring to detect any deterioration in respiratory status. (See
         <a class="local">
          'Exposure avoidance and returning to work'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prognosis
         </strong>
         – The majority of patients with IIA improve over time, although many continue to have some respiratory symptoms for at least a year and have physiologic abnormalities such as nonspecific bronchial hyperresponsiveness for several years. (See
         <a class="local">
          'Prognosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H10537134">
         <span class="h1">
          ACKNOWLEDGMENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Denyse Gautrin, MD, Moira Chan-Yeung, MD, Jean-Luc Malo, MD, André Cartier, MD, and Louis-Philippe Boulet, MD who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Brooks SM, Weiss MA, Bernstein IL. Reactive airways dysfunction syndrome (RADS). Persistent asthma syndrome after high level irritant exposures. Chest 1985; 88:376.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tarlo SM, Balmes J, Balkissoon R, et al. Diagnosis and management of work-related asthma: American College Of Chest Physicians Consensus Statement. Chest 2008; 134:1S.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vandenplas O, Wiszniewska M, Raulf M, et al. EAACI position paper: irritant-induced asthma. Allergy 2014; 69:1141.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Das R, Blanc PD. Chlorine gas exposure and the lung: a review. Toxicol Ind Health 1993; 9:439.
          </a>
         </li>
         <li class="breakAll">
          Winternitz, MC. Collected studies on the pathology of war gas poisoning, Yale University Press, New Haven 1920. p.1.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weill H, George R, Schwarz M, Ziskind M. Late evaluation of pulmonary function after acute exposure to chlorine gas. Am Rev Respir Dis 1969; 99:374.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Härkönen H, Nordman H, Korhonen O, Winblad I. Long-term effects of exposure to sulfur dioxide. Lung function four years after a pyrite dust explosion. Am Rev Respir Dis 1983; 128:890.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prezant DJ, Weiden M, Banauch GI, et al. Cough and bronchial responsiveness in firefighters at the World Trade Center site. N Engl J Med 2002; 347:806.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Banauch GI, Alleyne D, Sanchez R, et al. Persistent hyperreactivity and reactive airway dysfunction in firefighters at the World Trade Center. Am J Respir Crit Care Med 2003; 168:54.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lemière C, Malo JL, Gautrin D. Nonsensitizing causes of occupational asthma. Med Clin North Am 1996; 80:749.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kipen HM, Blume R, Hutt D. Asthma experience in an occupational and environmental medicine clinic. Low-dose reactive airways dysfunction syndrome. J Occup Med 1994; 36:1133.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brooks SM, Hammad Y, Richards I, et al. The spectrum of irritant-induced asthma: sudden and not-so-sudden onset and the role of allergy. Chest 1998; 113:42.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Quirce S, Gala G, Pérez-Camo I, et al. Irritant-induced asthma: clinical and functional aspects. J Asthma 2000; 37:267.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adewole F, Moore VC, Robertson AS, Burge PS. Diesel exhaust causing low-dose irritant asthma with latency? Occup Med (Lond) 2009; 59:424.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Burge PS, Moore VC, Robertson AS. Sensitization and irritant-induced occupational asthma with latency are clinically indistinguishable. Occup Med (Lond) 2012; 62:129.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang-Yeung M, Lam S, Kennedy SM, Frew AJ. Persistent asthma after repeated exposure to high concentrations of gases in pulpmills. Am J Respir Crit Care Med 1994; 149:1676.
          </a>
         </li>
         <li class="breakAll">
          Brooks SM, Malo J-L, Gautrin D. Irritant-induced asthma and reactive airways dysfunction syndrome. In: Asthma in the workplace, 4th, Malo J-L, Chan-Yeung M, Bernstein DI (Eds), CRC Press, Boca Raton FL 2013.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blanc PD, Galbo M, Hiatt P, et al. Symptoms, lung function, and airway responsiveness following irritant inhalation. Chest 1993; 103:1699.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cullinan P, Acquilla S, Dhara VR. Respiratory morbidity 10 years after the Union Carbide gas leak at Bhopal: a cross sectional survey. The International Medical Commission on Bhopal. BMJ 1997; 314:338.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dhara VR, Cullinan P. Bhopal priorities. Int J Occup Environ Health 2004; 10:107.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tarlo SM. Workplace irritant exposures: do they produce true occupational asthma? Ann Allergy Asthma Immunol 2003; 90:19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gautrin D, Leroyer C, L'Archevêque J, et al. Cross-sectional assessment of workers with repeated exposure to chlorine over a three year period. Eur Respir J 1995; 8:2046.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kern DG. Outbreak of the reactive airways dysfunction syndrome after a spill of glacial acetic acid. Am Rev Respir Dis 1991; 144:1058.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bhérer L, Cushman R, Courteau JP, et al. Survey of construction workers repeatedly exposed to chlorine over a three to six month period in a pulpmill: II. Follow up of affected workers by questionnaire, spirometry, and assessment of bronchial responsiveness 18 to 24 months after exposure ended. Occup Environ Med 1994; 51:225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gautrin D, Leroyer C, Infante-Rivard C, et al. Longitudinal assessment of airway caliber and responsiveness in workers exposed to chlorine. Am J Respir Crit Care Med 1999; 160:1232.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kogevinas M, Antó JM, Sunyer J, et al. Occupational asthma in Europe and other industrialised areas: a population-based study. European Community Respiratory Health Survey Study Group. Lancet 1999; 353:1750.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenman KD, Reilly MJ, Schill DP, et al. Cleaning products and work-related asthma. J Occup Environ Med 2003; 45:556.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Folletti I, Siracusa A, Paolocci G. Update on asthma and cleaning agents. Curr Opin Allergy Clin Immunol 2017; 17:90.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Henneberger PK, Derk SJ, Davis L, et al. Work-related reactive airways dysfunction syndrome cases from surveillance in selected US states. J Occup Environ Med 2003; 45:360.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Siracusa A, De Blay F, Folletti I, et al. Asthma and exposure to cleaning products - a European Academy of Allergy and Clinical Immunology task force consensus statement. Allergy 2013; 68:1532.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vizcaya D, Mirabelli MC, Orriols R, et al. Functional and biological characteristics of asthma in cleaning workers. Respir Med 2013; 107:673.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vandenplas O, D'Alpaos V, Evrard G, et al. Asthma related to cleaning agents: a clinical insight. BMJ Open 2013; 3:e003568.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Le Moual N, Varraso R, Siroux V, et al. Domestic use of cleaning sprays and asthma activity in females. Eur Respir J 2012; 40:1381.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenman K, Reilly MJ, Pechter E, et al. Cleaning Products and Work-Related Asthma, 10 Year Update. J Occup Environ Med 2020; 62:130.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tarlo SM, Broder I. Irritant-induced occupational asthma. Chest 1989; 96:297.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wheeler K, McKelvey W, Thorpe L, et al. Asthma diagnosed after 11 September 2001 among rescue and recovery workers: findings from the World Trade Center Health Registry. Environ Health Perspect 2007; 115:1584.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Banauch GI, Dhala A, Prezant DJ. Pulmonary disease in rescue workers at the World Trade Center site. Curr Opin Pulm Med 2005; 11:160.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Feldman DM, Baron SL, Bernard BP, et al. Symptoms, respirator use, and pulmonary function changes among New York City firefighters responding to the World Trade Center disaster. Chest 2004; 125:1256.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dumas O, Laurent E, Bousquet J, et al. Occupational irritants and asthma: an Estonian cross-sectional study of 34,000 adults. Eur Respir J 2014; 44:647.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shakeri MS, Dick FD, Ayres JG. Which agents cause reactive airways dysfunction syndrome (RADS)? A systematic review. Occup Med (Lond) 2008; 58:205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walters GI, Huntley CC. Updated review of reported cases of reactive airways dysfunction syndrome. Occup Med (Lond) 2020; 70:490.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baur X, Bakehe P, Vellguth H. Bronchial asthma and COPD due to irritants in the workplace - an evidence-based approach. J Occup Med Toxicol 2012; 7:19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lindström I, Lantto J, Karvala K, et al. Occupations and exposure events in acute and subacute irritant-induced asthma. Occup Environ Med 2021; 78:793.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Faria VS, da Silva SAEHC, Marchini JFM. Reactive airways dysfunction syndrome following inhalation of hydrogen chloride vapor. Autops Case Rep 2021; 11:e2021266.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andersson E, Olin AC, Hagberg S, et al. Adult-onset asthma and wheeze among irritant-exposed bleachery workers. Am J Ind Med 2003; 43:532.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Karjalainen A, Martikainen R, Karjalainen J, et al. Excess incidence of asthma among Finnish cleaners employed in different industries. Eur Respir J 2002; 19:90.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de la Hoz RE, Shohet MR, Chasan R, et al. Occupational toxicant inhalation injury: the World Trade Center (WTC) experience. Int Arch Occup Environ Health 2008; 81:479.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de la Hoz RE, Shohet MR, Wisnivesky JP, et al. Atopy and upper and lower airway disease among former World Trade Center workers and volunteers. J Occup Environ Med 2009; 51:992.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sherman CB, Barnhart S, Miller MF, et al. Firefighting acutely increases airway responsiveness. Am Rev Respir Dis 1989; 140:185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim H, Herbert R, Landrigan P, et al. Increased rates of asthma among World Trade Center disaster responders. Am J Ind Med 2012; 55:44.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rava M, Ahmed I, Kogevinas M, et al. Genes Interacting with Occupational Exposures to Low Molecular Weight Agents and Irritants on Adult-Onset Asthma in Three European Studies. Environ Health Perspect 2017; 125:207.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lemière C, Malo JL, Boulet LP, Boutet M. Reactive airways dysfunction syndrome induced by exposure to a mixture containing isocyanate: functional and histopathologic behaviour. Allergy 1996; 51:262.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lemière C, Malo JL, Boutet M. Reactive airways dysfunction syndrome due to chlorine: sequential bronchial biopsies and functional assessment. Eur Respir J 1997; 10:241.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Demnati R, Fraser R, Martin JG, et al. Effects of dexamethasone on functional and pathological changes in rat bronchi caused by high acute exposure to chlorine. Toxicol Sci 1998; 45:242.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martin JG, Campbell HR, Iijima H, et al. Chlorine-induced injury to the airways in mice. Am J Respir Crit Care Med 2003; 168:568.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van Den Broucke S, Pollaris L, Vande Velde G, et al. Irritant-induced asthma to hypochlorite in mice due to impairment of the airway barrier. Arch Toxicol 2018; 92:1551.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McGovern TK, Goldberger M, Allard B, et al. Neutrophils mediate airway hyperresponsiveness after chlorine-induced airway injury in the mouse. Am J Respir Cell Mol Biol 2015; 52:513.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McGovern T, Day BJ, White CW, et al. AEOL10150: a novel therapeutic for rescue treatment after toxic gas lung injury. Free Radic Biol Med 2011; 50:602.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Takeda N, Maghni K, Daigle S, et al. Long-term pathologic consequences of acute irritant-induced asthma. J Allergy Clin Immunol 2009; 124:975.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gautrin D, Boulet LP, Boutet M, et al. Is reactive airways dysfunction syndrome a variant of occupational asthma? J Allergy Clin Immunol 1994; 93:12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andrianjafimasy MV, Febrissy M, Zerimech F, et al. Association between occupational exposure to irritant agents and a distinct asthma endotype in adults. Occup Environ Med 2022; 79:155.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cone JE, Wugofski L, Balmes JR, et al. Persistent respiratory health effects after a metam sodium pesticide spill. Chest 1994; 106:500.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meggs WJ. RADS and RUDS--the toxic induction of asthma and rhinitis. J Toxicol Clin Toxicol 1994; 32:487.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           White CW, Martin JG. Chlorine gas inhalation: human clinical evidence of toxicity and experience in animal models. Proc Am Thorac Soc 2010; 7:257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Malo JL, L'archevêque J, Castellanos L, et al. Long-term outcomes of acute irritant-induced asthma. Am J Respir Crit Care Med 2009; 179:923.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mauer MP, Cummings KR, Hoen R. Long-term respiratory symptoms in World Trade Center responders. Occup Med (Lond) 2010; 60:145.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shusterman, D. Upper and lower airway sequelae of irritant inhalations. Clin Pulm Med 1999; 6:18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Courteau JP, Cushman R, Bouchard F, et al. Survey of construction workers repeatedly exposed to chlorine over a three to six month period in a pulpmill: I. Exposure and symptomatology. Occup Environ Med 1994; 51:219.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vandenplas O, Fievez P, Delwiche JP, et al. Persistent asthma following accidental exposure to formaldehyde. Allergy 2004; 59:115.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Charan NB, Lakshminarayan S, Myers GC, Smith DD. Effects of accidental chlorine inhalation on pulmonary function. West J Med 1985; 143:333.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stanojevic S, Kaminsky DA, Miller MR, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J 2022; 60.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de la Hoz RE. Occupational lower airway disease in relation to World Trade Center inhalation exposure. Curr Opin Allergy Clin Immunol 2011; 11:97.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leroyer C, Perfetti L, Cartier A, Malo JL. Can reactive airways dysfunction syndrome (RADS) transform into occupational asthma due to "sensitisation" to isocyanates? Thorax 1998; 53:152.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mendelson DS, Roggeveen M, Levin SM, et al. Air trapping detected on end-expiratory high-resolution computed tomography in symptomatic World Trade Center rescue and recovery workers. J Occup Environ Med 2007; 49:840.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zock JP, Kogevinas M, Sunyer J, et al. Asthma characteristics in cleaning workers, workers in other risk jobs and office workers. Eur Respir J 2002; 20:679.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hoyle GW, Svendsen ER. Persistent effects of chlorine inhalation on respiratory health. Ann N Y Acad Sci 2016; 1378:33.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Perkner JJ, Fennelly KP, Balkissoon R, et al. Irritant-associated vocal cord dysfunction. J Occup Environ Med 1998; 40:136.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Quirce S. Eosinophilic bronchitis in the workplace. Curr Opin Allergy Clin Immunol 2004; 4:87.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tanaka H, Saikai T, Sugawara H, et al. Workplace-related chronic cough on a mushroom farm. Chest 2002; 122:1080.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wiszniewska M, Dellis P, van Kampen V, et al. Characterization of Occupational Eosinophilic Bronchitis in a Multicenter Cohort of Subjects with Work-Related Asthma Symptoms. J Allergy Clin Immunol Pract 2021; 9:937.
          </a>
         </li>
         <li class="breakAll">
          2023 Global Initiative for Asthma (GINA) Report: Global Strategy for Asthma Management and Prevention. www.ginasthma.org/2023-gina-main-report (Accessed on May 15, 2023).
         </li>
         <li class="breakAll">
          National Asthma Education and Prevention Program: Expert panel report III: Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Heart, Lung, and Blood Institute, 2007. (NIH publication no. 08-4051) www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm (Accessed on January 26, 2016).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Malo JL, Cartier A, Boulet LP, et al. Bronchial hyperresponsiveness can improve while spirometry plateaus two to three years after repeated exposure to chlorine causing respiratory symptoms. Am J Respir Crit Care Med 1994; 150:1142.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leroyer C, Malo JL, Girard D, et al. Chronic rhinitis in workers at risk of reactive airways dysfunction syndrome due to exposure to chlorine. Occup Environ Med 1999; 56:334.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jones RN, Hughes JM, Glindmeyer H, Weill H. Lung function after acute chlorine exposure. Am Rev Respir Dis 1986; 134:1190.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Emad A, Rezaian GR. The diversity of the effects of sulfur mustard gas inhalation on respiratory system 10 years after a single, heavy exposure: analysis of 197 cases. Chest 1997; 112:734.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lantto J, Suojalehto H, Lindström I. Long-Term Outcome of Occupational Asthma From Irritants and Low-Molecular-Weight Sensitizers. J Allergy Clin Immunol Pract 2023; 11:1224.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aldrich TK, Gustave J, Hall CB, et al. Lung function in rescue workers at the World Trade Center after 7 years. N Engl J Med 2010; 362:1263.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Skloot GS, Schechter CB, Herbert R, et al. Longitudinal assessment of spirometry in the World Trade Center medical monitoring program. Chest 2009; 135:492.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 536 Version 38.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4028848" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Reactive airways dysfunction syndrome (RADS). Persistent asthma syndrome after high level irritant exposures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18779187" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Diagnosis and management of work-related asthma: American College Of Chest Physicians Consensus Statement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24854136" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : EAACI position paper: irritant-induced asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8367885" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Chlorine gas exposure and the lung: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8367885" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Chlorine gas exposure and the lung: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5765629" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Late evaluation of pulmonary function after acute exposure to chlorine gas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6638677" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Long-term effects of exposure to sulfur dioxide. Lung function four years after a pyrite dust explosion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12226151" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Cough and bronchial responsiveness in firefighters at the World Trade Center site.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12615613" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Persistent hyperreactivity and reactive airway dysfunction in firefighters at the World Trade Center.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8676613" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Nonsensitizing causes of occupational asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7830173" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Asthma experience in an occupational and environmental medicine clinic. Low-dose reactive airways dysfunction syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9440566" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : The spectrum of irritant-induced asthma: sudden and not-so-sudden onset and the role of allergy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10831151" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Irritant-induced asthma: clinical and functional aspects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19692525" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Diesel exhaust causing low-dose irritant asthma with latency?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22199365" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Sensitization and irritant-induced occupational asthma with latency are clinically indistinguishable.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8004329" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Persistent asthma after repeated exposure to high concentrations of gases in pulpmills.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8004329" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Persistent asthma after repeated exposure to high concentrations of gases in pulpmills.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8404087" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Symptoms, lung function, and airway responsiveness following irritant inhalation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9040323" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Respiratory morbidity 10 years after the Union Carbide gas leak at Bhopal: a cross sectional survey. The International Medical Commission on Bhopal.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15070035" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Bhopal priorities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12772946" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Workplace irritant exposures: do they produce true occupational asthma?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8666099" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Cross-sectional assessment of workers with repeated exposure to chlorine over a three year period.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1952431" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Outbreak of the reactive airways dysfunction syndrome after a spill of glacial acetic acid.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8199662" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Survey of construction workers repeatedly exposed to chlorine over a three to six month period in a pulpmill: II. Follow up of affected workers by questionnaire, spirometry, and assessment of bronchial responsiveness 18 to 24 months after exposure ended.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10508812" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Longitudinal assessment of airway caliber and responsiveness in workers exposed to chlorine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10347988" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Occupational asthma in Europe and other industrialised areas: a population-based study. European Community Respiratory Health Survey Study Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12762081" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Cleaning products and work-related asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28141626" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Update on asthma and cleaning agents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12708139" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Work-related reactive airways dysfunction syndrome cases from surveillance in selected US states.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24131133" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Asthma and exposure to cleaning products - a European Academy of Allergy and Clinical Immunology task force consensus statement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23433770" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Functional and biological characteristics of asthma in cleaning workers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24056489" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Asthma related to cleaning agents: a clinical insight.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22496323" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Domestic use of cleaning sprays and asthma activity in females.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31895737" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Cleaning Products and Work-Related Asthma, 10 Year Update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2666043" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Irritant-induced occupational asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18007989" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Asthma diagnosed after 11 September 2001 among rescue and recovery workers: findings from the World Trade Center Health Registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15699790" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Pulmonary disease in rescue workers at the World Trade Center site.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15078732" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Symptoms, respirator use, and pulmonary function changes among New York City firefighters responding to the World Trade Center disaster.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24743968" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Occupational irritants and asthma: an Estonian cross-sectional study of 34,000 adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18308694" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Which agents cause reactive airways dysfunction syndrome (RADS)? A systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33063819" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Updated review of reported cases of reactive airways dysfunction syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23013890" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Bronchial asthma and COPD due to irritants in the workplace - an evidence-based approach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33790028" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Occupations and exposure events in acute and subacute irritant-induced asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33968833" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Reactive airways dysfunction syndrome following inhalation of hydrogen chloride vapor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12704626" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Adult-onset asthma and wheeze among irritant-exposed bleachery workers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11843333" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Excess incidence of asthma among Finnish cleaners employed in different industries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17786467" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Occupational toxicant inhalation injury: the World Trade Center (WTC) experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19730399" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Atopy and upper and lower airway disease among former World Trade Center workers and volunteers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2665585" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Firefighting acutely increases airway responsiveness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22068920" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Increased rates of asthma among World Trade Center disaster responders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27504716" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Genes Interacting with Occupational Exposures to Low Molecular Weight Agents and Irritants on Adult-Onset Asthma in Three European Studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8792924" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Reactive airways dysfunction syndrome induced by exposure to a mixture containing isocyanate: functional and histopathologic behaviour.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9032521" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Reactive airways dysfunction syndrome due to chlorine: sequential bronchial biopsies and functional assessment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9848131" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Effects of dexamethasone on functional and pathological changes in rat bronchi caused by high acute exposure to chlorine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12724121" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Chlorine-induced injury to the airways in mice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29368146" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Irritant-induced asthma to hypochlorite in mice due to impairment of the airway barrier.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25192041" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Neutrophils mediate airway hyperresponsiveness after chlorine-induced airway injury in the mouse.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21156205" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : AEOL10150: a novel therapeutic for rescue treatment after toxic gas lung injury.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19895985" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Long-term pathologic consequences of acute irritant-induced asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8308178" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Is reactive airways dysfunction syndrome a variant of occupational asthma?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34413158" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Association between occupational exposure to irritant agents and a distinct asthma endotype in adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7774327" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Persistent respiratory health effects after a metam sodium pesticide spill.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7932908" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : RADS and RUDS--the toxic induction of asthma and rhinitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20601629" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Chlorine gas inhalation: human clinical evidence of toxicity and experience in animal models.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19234102" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Long-term outcomes of acute irritant-induced asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20035001" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Long-term respiratory symptoms in World Trade Center responders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Upper and lower airway sequelae of irritant inhalations
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8199661" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Survey of construction workers repeatedly exposed to chlorine over a three to six month period in a pulpmill: I. Exposure and symptomatology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14674947" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Persistent asthma following accidental exposure to formaldehyde.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4049853" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Effects of accidental chlorine inhalation on pulmonary function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34949706" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : ERS/ATS technical standard on interpretive strategies for routine lung function tests.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21325944" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Occupational lower airway disease in relation to World Trade Center inhalation exposure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9624303" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Can reactive airways dysfunction syndrome (RADS) transform into occupational asthma due to "sensitisation" to isocyanates?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17693781" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Air trapping detected on end-expiratory high-resolution computed tomography in symptomatic World Trade Center rescue and recovery workers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12358347" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Asthma characteristics in cleaning workers, workers in other risk jobs and office workers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27385061" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Persistent effects of chlorine inhalation on respiratory health.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9503289" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Irritant-associated vocal cord dysfunction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15021059" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Eosinophilic bronchitis in the workplace.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12226058" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Workplace-related chronic cough on a mushroom farm.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32920064" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Characterization of Occupational Eosinophilic Bronchitis in a Multicenter Cohort of Subjects with Work-Related Asthma Symptoms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32920064" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Characterization of Occupational Eosinophilic Bronchitis in a Multicenter Cohort of Subjects with Work-Related Asthma Symptoms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32920064" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Characterization of Occupational Eosinophilic Bronchitis in a Multicenter Cohort of Subjects with Work-Related Asthma Symptoms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7921449" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Bronchial hyperresponsiveness can improve while spirometry plateaus two to three years after repeated exposure to chlorine causing respiratory symptoms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10472308" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Chronic rhinitis in workers at risk of reactive airways dysfunction syndrome due to exposure to chlorine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3789518" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Lung function after acute chlorine exposure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9315808" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : The diversity of the effects of sulfur mustard gas inhalation on respiratory system 10 years after a single, heavy exposure: analysis of 197 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36572181" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Long-Term Outcome of Occupational Asthma From Irritants and Low-Molecular-Weight Sensitizers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20375403" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Lung function in rescue workers at the World Trade Center after 7 years.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19141527" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Longitudinal assessment of spirometry in the World Trade Center medical monitoring program.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
